Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Tswen-Kei Tang

Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents That Target the Interaction With Dbf4 by the Fragment Complementation and Drug Repositioning Approach

EBioMedicine

English

Biochemical and Immunological Studies of Nucleocapsid Proteins of Severe Acute Respiratory Syndrome and 229E Human Coronaviruses

English

Related publications

Drug Repositioning of Mevalonate Pathway Inhibitors as Antitumor Agents for Ovarian Cancer

Oncotarget

Oncology

2017

English

Computational Repositioning of Ethno Medicine Elucidated gB-gH-gL Complex as Novel Anti Herpes Drug Target

BMC Complementary and Alternative Medicine

English

From Oncogene to Drug: Development of Small Molecule Tyrosine Kinase Inhibitors as Anti-Tumor and Anti-Angiogenic Agents

English

Discovery of Novel Tricyclic Thiazepine Derivatives as Anti-Drug-Resistant Cancer Agents by Combining Diversity-Oriented Synthesis and Converging Screening Approach

English

Matrix Metalloproteinase9 as the Protein Target in Anti-Breast Cancer Drug Discovery: An Approach by Targeting Hemopexin Domain

Future Journal of Pharmaceutical Sciences

2019

English

Systematic Approach for Drug Repositioning of Anti-Epileptic Drugs

Diagnostics

Clinical Biochemistry

2019

English

Discovery of Novel KRAS-PDE Inhibitors by Fragment-Based Drug Design

English

LEDGF/p75 IN Interaction Inhibitors: In Silico Studies of an Old Target With Novel Approach

BMC Infectious Diseases

Infectious Diseases

2014

English

Fragment-Based Drug Design and Drug Repositioning Using Multiple Ligand Simultaneous Docking (MLSD): Identifying Celecoxib and Template Compounds as Novel Inhibitors of Signal Transducer and Activator of Transcription 3 (STAT3)

Journal of Medicinal Chemistry

Drug Discovery

Molecular Medicine

2011

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Tswen-Kei Tang

Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents That Target the Interaction With Dbf4 by the Fragment Complementation and Drug Repositioning Approach

Biochemical and Immunological Studies of Nucleocapsid Proteins of Severe Acute Respiratory Syndrome and 229E Human Coronaviruses

Related publications

Drug Repositioning of Mevalonate Pathway Inhibitors as Antitumor Agents for Ovarian Cancer

Computational Repositioning of Ethno Medicine Elucidated gB-gH-gL Complex as Novel Anti Herpes Drug Target

From Oncogene to Drug: Development of Small Molecule Tyrosine Kinase Inhibitors as Anti-Tumor and Anti-Angiogenic Agents

Discovery of Novel Tricyclic Thiazepine Derivatives as Anti-Drug-Resistant Cancer Agents by Combining Diversity-Oriented Synthesis and Converging Screening Approach

Matrix Metalloproteinase9 as the Protein Target in Anti-Breast Cancer Drug Discovery: An Approach by Targeting Hemopexin Domain

Systematic Approach for Drug Repositioning of Anti-Epileptic Drugs

Discovery of Novel KRAS-PDE Inhibitors by Fragment-Based Drug Design

LEDGF/p75 IN Interaction Inhibitors: In Silico Studies of an Old Target With Novel Approach

Fragment-Based Drug Design and Drug Repositioning Using Multiple Ligand Simultaneous Docking (MLSD): Identifying Celecoxib and Template Compounds as Novel Inhibitors of Signal Transducer and Activator of Transcription 3 (STAT3)